According to Longboard Pharmaceuticals's latest financial reports the company has $48.49 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $48.49 M | -28.25% |
2022-12-31 | $67.58 M | -36.67% |
2021-12-31 | $0.10 B | 92.94% |
2020-12-31 | $55.31 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 329.27% | ๐บ๐ธ USA |